Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
1.
Eur J Med Genet ; 62(5): 350-356, 2019 May.
Article de Anglais | MEDLINE | ID: mdl-30503855

RÉSUMÉ

Whole genome sequencing (WGS) is a transformative technology which promises improved diagnostic rates compared to conventional genetic testing strategies and tailored approaches to patient care. Due to the practical and ethical complexities associated with using WGS, particularly in the paediatric context, input from a broad spectrum of healthcare providers can guide implementation strategies. We recruited healthcare providers from the largest paediatric academic health science centre in Canada and conducted semi-structured qualitative interviews, exploring experiences with and perceptions of the opportunities and challenges associated with WGS. Interview transcripts were coded and analyzed thematically. Interviews were completed with 14 genetics professionals (geneticists and genetic counsellors) and 15 non-genetics professionals (physician sub-specialists and nurses). Genetics professionals ordered genetic tests more often and reported greater confidence on pre- and post-test genetic counselling compared to non-genetics professionals. Most healthcare providers endorsed WGS when a more specific test was either not available or not likely to yield a diagnosis. While genetics professionals raised concerns regarding the time demands associated with reviewing WGS variants, non-genetics professionals reflected concerns about knowledge and training. Providers' position on reporting secondary variants to parents drew upon but was not limited to the concept of best interests. Taken together, understanding practical and principled matters of WGS from healthcare providers' perspectives can guide ongoing efforts to implement WGS in paediatrics.


Sujet(s)
Attitude du personnel soignant , Dépistage génétique/méthodes , Personnel de santé/psychologie , Pédiatrie/méthodes , Séquençage du génome entier , Adulte , Femelle , Humains , Mâle
2.
J Med Ethics ; 43(8): 535-539, 2017 08.
Article de Anglais | MEDLINE | ID: mdl-27888232

RÉSUMÉ

OBJECTIVE: To better understand the consequences of returning whole genome sequencing (WGS) results in paediatrics and facilitate its evidence-based clinical implementation, we studied parents' experiences with WGS and their preferences for the return of adult-onset secondary variants (SVs)-medically actionable genomic variants unrelated to their child's current medical condition that predict adult-onset disease. METHODS: We conducted qualitative interviews with parents whose children were undergoing WGS as part of the SickKids Genome Clinic, a research project that studies the impact of clinical WGS on patients, families, and the healthcare system. Interviews probed parents' experience with and motivation for WGS as well as their preferences related to SVs. Interviews were analysed thematically. RESULTS: Of 83 invited, 23 parents from 18 families participated. These parents supported WGS as a diagnostic test, perceiving clear intrinsic and instrumental value. However, many parents were ambivalent about receiving SVs, conveying a sense of self-imposed obligation to take on the 'weight' of knowing their child's SVs, however unpleasant. Some parents chose to learn about adult-onset SVs for their child but not for themselves. CONCLUSIONS: Despite general enthusiasm for WGS as a diagnostic test, many parents felt a duty to learn adult-onset SVs. Analogous to 'inflicted insight', we call this phenomenon 'inflicted ought'. Importantly, not all parents of children undergoing WGS view the best interests of their child in relational terms, thereby challenging an underlying justification for current ACMG guidelines for reporting incidental secondary findings from whole exome and WGS.


Sujet(s)
Dépistage génétique , Connaissances, attitudes et pratiques en santé , Résultats fortuits , Obligations morales , Relations parent-enfant , Parents , Séquençage du génome entier , Adulte , Enfant , Enfant d'âge préscolaire , Comportement de choix , Divulgation , Femelle , Variation génétique , Génome humain , Génomique , Humains , Nourrisson , Nouveau-né , Mâle , Motivation , Pédiatrie , Recherche qualitative , Enquêtes et questionnaires
3.
Clin Genet ; 89(1): 10-9, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-25813238

RÉSUMÉ

Our increasing knowledge of how genomic variants affect human health and the falling costs of whole-genome sequencing are driving the development of individualized genomic medicine. This new clinical paradigm uses knowledge of an individual's genomic variants to anticipate, diagnose and manage disease. While individualized genetic medicine offers the promise of transformative change in health care, it forces us to reconsider existing ethical, scientific and clinical paradigms. The potential benefits of pre-symptomatic identification of at-risk individuals, improved diagnostics, individualized therapy, accurate prognosis and avoidance of adverse drug reactions coexist with the potential risks of uninterpretable results, psychological harm, outmoded counseling models and increased health care costs. Here we review the challenges, opportunities and limits of integrating genomic analysis into pediatric clinical practice and describe a model for implementing individualized genomic medicine. Our multidisciplinary team of bioinformaticians, health economists, health services and policy researchers, ethicists, geneticists, genetic counselors and clinicians has designed a 'Genome Clinic' research project that addresses multiple challenges in pediatric genomic medicine--ranging from development of bioinformatics tools for the clinical assessment of genomic variants and the discovery of disease genes to health policy inquiries, assessment of clinical care models, patient preference and the ethics of consent.


Sujet(s)
Dépistage génétique , Génétique médicale , Génome humain , Génomique , Pédiatrie , Médecine de précision , Déontologie médicale , Conseil génétique , Prédisposition génétique à une maladie , Dépistage génétique/éthique , Dépistage génétique/méthodes , Dépistage génétique/normes , Génétique médicale/éthique , Génétique médicale/méthodes , Génétique médicale/normes , Génomique/éthique , Génomique/méthodes , Génomique/tendances , Humains , Pédiatrie/méthodes , Pédiatrie/normes , Médecine de précision/éthique , Médecine de précision/méthodes , Médecine de précision/normes , Reproductibilité des résultats , Sensibilité et spécificité
4.
Clin Genet ; 87(4): 301-10, 2015 Apr.
Article de Anglais | MEDLINE | ID: mdl-25046648

RÉSUMÉ

The publication of the ACMG recommendations has reignited the debate over predictive testing for adult-onset disorders in minors. Response has been polarized. With this in mind, we review and critically analyze this debate. First, we identify long-standing inconsistencies between consensus guidelines and clinical practice regarding risk assessment for adult-onset genetic disorders in children using family history and molecular analysis. Second, we discuss the disparate assumptions regarding the nature of whole genome and exome sequencing underlying arguments of both supporters and critics, and the role these assumptions play in the arguments for and against reporting. Third, we suggest that implicit differences regarding the definition of best interests of the child underlie disparate conclusions as to the best interests of children in this context. We conclude by calling for clarity and consensus concerning the central foci of this debate.


Sujet(s)
Divulgation/éthique , Dépistage génétique/méthodes , Recommandations comme sujet/normes , Résultats fortuits , Adulte , Âge de début , Enfant , Dépistage génétique/éthique , Humains , Mineurs , Valeur prédictive des tests , Analyse de séquence d'ADN/méthodes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...